Susan Bakke

1.7k total citations
12 papers, 1.4k citations indexed

About

Susan Bakke is a scholar working on Oncology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Susan Bakke has authored 12 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Surgery and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Susan Bakke's work include Drug Transport and Resistance Mechanisms (6 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Susan Bakke is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Susan Bakke collaborates with scholars based in United States, Israel and Netherlands. Susan Bakke's co-authors include Susan E. Bates, Robert W. Robey, Richard Piekarz, Victor Sandor, Barry R. Goldspiel, Tito Fojo, Min H. Kang, Wyndham H. Wilson, Maria L. Turner and Laila Dahmoush and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Susan Bakke

12 papers receiving 1.4k citations

Peers

Countries citing papers authored by Susan Bakke

Since Specialization

Citations

This map shows the geographic impact of Susan Bakke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Bakke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Bakke more than expected).

Fields of papers citing papers by Susan Bakke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Bakke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Bakke. The network helps show where Susan Bakke may publish in the future.

Co-authorship network of co-authors of Susan Bakke

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Bakke. A scholar is included among the top collaborators of Susan Bakke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Bakke. Susan Bakke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Design and methods for a pilot randomized clinical trial involving exercise and behavioral activation to treat comorbid type 2 diabetes and major depressive disorder 2011 ·Mental health and physical activity ·Kristin L. Schneider, Sherry Pagoto, (unknown), Emily Panza, Susan Bakke, Qin Liu, Mihaela C. Blendea, Ira S. Ockene, Yunsheng Ma	16
2	A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine 2009 ·Clinical Cancer Research ·Jame Abraham, Maureen Edgerly, Richard H. Wilson, Clara Chen, Ann Rutt, Susan Bakke, Robert W. Robey, (unknown), Barry R. Goldspiel, Frank M. Balis, Olaf van Tellingen, Susan E. Bates, Tito Fojo	93
3	A Phase I clinical trial of ixabepilone (BMS‐247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days 2005 ·Cancer ·Sen Hong Zhuang, Manish Agrawal, Maureen Edgerly, Susan Bakke, Herb Kotz, (unknown), Ann Rutt, Frank M. Balis, Susan E. Bates, Tito Fojo	61
4	A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma 2004 ·Clinical Cancer Research ·Susan E. Bates, Susan Bakke, Min H. Kang, Robert W. Robey, Suoping Zhai, (unknown), Clara C. Chen, (unknown), Tom Smith, Seth M. Steinberg, Maria Merino, Barry R. Goldspiel, Beverly Meadows, Wilfred D. Stein, Peter Choyke, Frank M. Balis, William D. Figg, Tito Fojo	56
5	Phase I Trial and Pharmacokinetic Study of BMS-247550, an Epothilone B Analog, Administered Intravenously on a Daily Schedule for Five Days 2003 ·Journal of Clinical Oncology ·Jame Abraham, Manish Agrawal, Susan Bakke, Ann Rutt, Maureen Edgerly, Frank M. Balis, Brigitte C. Widemann, (unknown), Bharat Damle, Daryl Sonnichsen, David Lebwohl, Susan E. Bates, Herb Kotz, Tito Fojo	113
6	A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma 2002 ·Cancer ·Jame Abraham, Susan Bakke, Ann Rutt, Beverly Meadows, Maria Merino, Richard H. Alexander, David S. Schrump, David B. Bartlett, Peter Choyke, Robert W. Robey, (unknown), Seth M. Steinberg, Susan E. Bates, Tito Fojo	82
7	Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. 2002 ·PubMed ·Victor Sandor, Susan Bakke, Robert W. Robey, Min H. Kang, Mikhail V. Blagosklonny, (unknown), Rebecca Brooks, Richard Piekarz, Eben Tucker, William D. Figg, Kenneth K. Chan, Barry R. Goldspiel, Antonio Tito Fojo, Stanley P. Balcerzak, Susan E. Bates	435
8	A Phase I study of infusional vinblastine in combination with the p-glycoprotein antagonist PSC 833 (valspodar) 2001 ·Cancer ·Susan E. Bates, Min H. Kang, Beverly Meadows, Susan Bakke, Peter Choyke, Maria Merino, Barry R. Goldspiel, (unknown), Tom Smith, Clara Chen, Robert W. Robey, Raymond C. Bergan, William D. Figg, Tito Fojo	63
9	Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report 2001 ·Blood ·Richard Piekarz, Robert W. Robey, Victor Sandor, Susan Bakke, Wyndham H. Wilson, Laila Dahmoush, (unknown), Maria L. Turner, Rosemary M. Altemus, Susan E. Bates	367
10	Phase I Study of Infusional Paclitaxel in Combination With the P-Glycoprotein Antagonist PSC 833 2001 ·Journal of Clinical Oncology ·(unknown), Min H. Kang, Raymond C. Bergan, Jame Abraham, Susan Bakke, Beverly Meadows, Ann Rutt, Robert W. Robey, Peter L. Choyke, Maria Merino, Barry R. Goldspiel, Tom Smith, Seth M. Steinberg, William D. Figg, Tito Fojo, Susan E. Bates	65
11	Efflux of Rhodamine From CD56+ Cells as a Surrogate Marker for Reversal of P-Glycoprotein–Mediated Drug Efflux by PSC 833 1999 ·Blood ·Robert W. Robey, Susan Bakke, Wilfred D. Stein, Beverly Meadows, Thomas Litman, (unknown), Tom Smith, Tito Fojo, Susan E. Bates	57
12	Efflux of Rhodamine From CD56+ Cells as a Surrogate Marker for Reversal of P-Glycoprotein–Mediated Drug Efflux by PSC 833 1999 ·Blood ·Robert W. Robey, Susan Bakke, Wilfred D. Stein, Beverly Meadows, Thomas Litman, (unknown), Tom Smith, Tito Fojo, Susan E. Bates	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact